captured official filings
Syra Health Corp
Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.
captured official filings
captured official filings
captured official filings
One evidence index instead of a manual filing hunt.
It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.
What teams can pay to automate next.
Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.
Public registration text delta
Comparing S-1 filed 2024-08-15 with S-1/A filed 2023-09-13.
Tracked-term count changes
Counts are navigation signals, not conclusions. Open both official filings to determine materiality.
- offering178 → 73-105
- shares154 → 52-102
- proceeds36 → 11-25
- management12 → 31+19
- dilution14 → 1-13
- control15 → 20+5
Candidate disclosure excerpts
Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.
- PRELIMINARY PROSPECTUS SUBJECT TO COMPLETION DATED SEPTEMBER 13, 2023 1,500,000 Units Shares of Class A Common Stock and Warrants Syra Health Corp.
- This is the initial public offering of units of securities (the “Units”) of Syra Health Corp.
- Prior to this offering, there has been no public market for shares of our Class A common stock.
- We are offering up to 3,787,878 shares of our Class A common stock, $0.001 par value per share (“Class A Common Stock”), together with Series A common stock purchase warrants to purchase up to 3,787,878 shares of Class A Common Stock (“Series A Warrants”) and Series B common stock purchase warrants to pur
- The shares of Class A Common Stock, Series A Warrants and Series B Warrants are immediately separable and will be issued separately in this offering, but must be purchased together in this offering.
- The assumed combined public offering price for each share of Class A Common Stock and accompanying Series A Warrant and Series B Warrant is $1.32, which was the closing price of our Class A Common Stock on The Nasdaq Capital Market on August 14, 2024.
Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.
Save a project-ready issuer record.
US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.
- Source-linked filing chronology and registration path
- Machine-detected amendment and tracked-term change view
- Official-source index for project-file archiving and downloadable CSV export
Secure checkout by PayPal.
Save this source-linked record
Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.
Captured filing chronology
- 8-KReporting & material eventsOpen SEC filing →
- DEF 14AGovernanceOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-K/AReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- DEF 14AGovernanceOpen SEC filing →
- PRE 14AGovernanceOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 424B4Registration & offeringOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- S-1Registration & offeringOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- DEF 14AGovernanceOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.